<code id='AEA1250557'></code><style id='AEA1250557'></style>
    • <acronym id='AEA1250557'></acronym>
      <center id='AEA1250557'><center id='AEA1250557'><tfoot id='AEA1250557'></tfoot></center><abbr id='AEA1250557'><dir id='AEA1250557'><tfoot id='AEA1250557'></tfoot><noframes id='AEA1250557'>

    • <optgroup id='AEA1250557'><strike id='AEA1250557'><sup id='AEA1250557'></sup></strike><code id='AEA1250557'></code></optgroup>
        1. <b id='AEA1250557'><label id='AEA1250557'><select id='AEA1250557'><dt id='AEA1250557'><span id='AEA1250557'></span></dt></select></label></b><u id='AEA1250557'></u>
          <i id='AEA1250557'><strike id='AEA1250557'><tt id='AEA1250557'><pre id='AEA1250557'></pre></tt></strike></i>

          
          WSS
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Leave your comment

          Please enter your name
          Please enter your comment

          hotspot